Publication Date:
2005-10-01
Description:
〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Grant, Robert M -- Buchbinder, Susan -- Cates, Willard Jr -- Clarke, Edith -- Coates, Thomas -- Cohen, Myron S -- Delaney, Martin -- Flores, Guiselly -- Goicochea, Pedro -- Gonsalves, Gregg -- Harrington, Mark -- Lama, Javier R -- MacQueen, Kathleen M -- Moore, John P -- Peterson, Leigh -- Sanchez, Jorge -- Thompson, Melanie -- Wainberg, Mark A -- New York, N.Y. -- Science. 2005 Sep 30;309(5744):2170-1.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Gladstone Institute of Virology and Immunology, San Francisco, CA, USA. rgrant@itsa.ucsf.edu〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/16195446" target="_blank"〉PubMed〈/a〉
Keywords:
Adenine/adverse effects/*analogs & derivatives/economics/therapeutic use
;
Africa
;
Anti-HIV Agents/adverse effects/economics/*therapeutic use
;
Asia
;
Consumer Participation
;
*Controlled Clinical Trials as Topic/standards
;
Counseling
;
Developing Countries
;
Drug Costs
;
Female
;
HIV Infections/*prevention & control
;
Health Services Accessibility
;
Humans
;
Latin America
;
Male
;
Organophosphonates/adverse effects/economics/*therapeutic use
;
Patient Selection
;
Tenofovir
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink